Peer Review History
| Original SubmissionDecember 28, 2024 |
|---|
|
Dear Dr. Eitner, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please find the reviewers comment below, we would appreciate a detailed review and specific response to each point raised by the reviewers. Please submit your revised manuscript by Apr 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mshari Alghadier Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. Thank you for stating in your Funding Statement: -->-->Support for the work was provided by Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung [BMBF], trial registration 13GW0299D).-->--> -->-->Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. -->-->Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.-->--> -->-->3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.-->?> [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: No Reviewer #5: Yes Reviewer #6: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: No Reviewer #5: Yes Reviewer #6: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: No Reviewer #6: No ********** Reviewer #1: Thank you for your work and an interesting study. Gamification use in paediatric therapy is a really interesting and growing area, and this is interesting how it combines the value of biodfeedback too. well done. i am excited about the concept and the potential future application, though perhaps some edits are needed to strengthen this work (particularily for any rehabilitation therapists who would be reading this). Abstract - edit phrasing to be "children with CP" - remove the word "only" before refused. Introduction - would it be worth adding some comment on this being a form of biofeedback (and what it known about biodfeedback)? Around line 63 it might be relevant to mention biofeedback here. -line 89: should the phrasing be "prior to the start" Methods note that GMFCS levels use roman numerals (I-V) How did you decide on which muscles to put the sensors on for each person (i.e. how did the physiotherapists decide on this)? Where the sensors placed across all of the muscle sites lists or were they targeted to the child? How did you ensure that the participants places the sensors on the correct locations at home? some of these muscles can be quite small, even more so on kids with CP- how do you avoid cross talk? Results line 211 "21 childen were contacted" Do you have data on how long they used the system each time (minutes?), then also some sort of indication on the number of repititions they might have made in a particular movement/contraction? This would greatly strengthen this work. Is there any option to also include some of the EMG or kinematic data within this manuscript? and how did it relate to the muscles that were needing to be targeted (e.g. in some cases it is not the muscle that we are aiming to recruit that is used to complete a task). line 220: Is 'hand joint' meaning wrist joint? and is it ankle joint for feet? (knee extension and ankle dorsi flexion?) You may want to check the formating of your tables so thaey are consistent (i.e. capital letters for Clinical data, Paresis etc). It is hard to work out how many participants had one or more sensors on them, or what combination of muscles they had tested at time, could this be explained (maybe table 2 could have more explanation?) line 234: 'episodes of dizziness"? line 236: how did the parent report the muscle pain but not the child? Perhaps within this section it might be helpful to keep referring to the child- participants as children (not patients) and the parent (participants) as parents. usability- removed the comma after 'Both' Discussion There is a flip back and forth between using CP and cerebral palsy. line 306: extra space before the full stop It feels like this is getting a little away from the application (and principles) of rehabilitation. Yes - specific task training is needed, and it generally applies to functional tasks based on the child’s therapy goals, that also need to active (not passive) – which is where the emg biofeedback approach is a positive step. "Engineer build training applications" could be misinterpreted here as being the solution. Cost of other systems is mentioned as prohibitive, what would the approximate cost be of this system? Can the game within the system be modified to suit children with higher GMFCS levels? These are the children who could likley benefit the most. How does this approach minimise fatigue? It might be important to comment that future work would be needed to evaluate if there are any functional changes with this tool. Reviewer #2: Thank you for giving me the opportunity to review the manuscript - Mighty U – A portable sensor-based video game application for exercise training of children and adolescents with cerebral palsy. Very interesting concept and very well-done study, though limited by the size of the sample. Never the less I hope it would pave way for larger studies. I recommend the publishing of the manuscript. Reviewer #3: This study explores the effectiveness and feasibility of a virtual reality application called *MightyU*, designed for home-based neuro-rehabilitation of children with cerebral palsy (CP). The application uses an electromyographic (EMG) sensor to monitor the muscular movements and motor capabilities of the children, providing an interactive gaming experience that stimulates both fine and gross motor training. ABSTRACT Lines 8-9: Could you clarify what you mean by "kinematic electromyography"? Are you referring exclusively to surface EMG? Line 24: Please provide the SUS score. INTRODUCTION Line 30: Replace "Infantile Cerebral Palsy" with "Cerebral Palsy (CP)". Line 31: Replace "affected individuals" with "individuals with CP". Line 34: Replace "affected children" with "children with CP". Line 54: Replace "cerebral palsy" with "CP". Line 60: Add a space before reference (10). Line 61: Replace "sensor-based surface EMG technology" with "surface EMG". Line 67: Replace "underscore" with "underline" (?) Line 68: Replace "CP patients" with "children with CP". Lines 73-78: Rephrase and avoid the numbered list. Try to combine the points into a coherent sentence. Line 78: Clarify the studies referenced (14-17). METHODS Line 82: Replace "subjects" with "participants". Line 87: Italicize "MightyU" and remove the quotation marks. Lines 93-94: Remove the brackets around "information technology". Line 95: Spell out the acronym "IT" as "information technology". Line 100: Provide a more detailed description of the movements and which muscles were targeted. Line 101: Specify the anatomical points where sensors were placed. Line 107: Replace "cerebral palsy" with "CP". Line 108: Remove the phrase "a recent work by". Line 110: Clarify how the surveys were distributed and structured. Line 117: Remove the word "special". Line 118: Specify the type of muscles or muscle groups targeted. Line 122: Clarify what you mean by "degree of muscle tension"—is it referring to the amplitude of the EMG signal? Line 123: Explain the calibration procedure or provide a reference for it. Line 129: Clarify what criteria were used to add an obstacle and how many more obstacles were quantified. Line 132: Specify which muscles were involved and explain how you determined if the maximum contraction was performed by the child. Line 142: Specify all the data collected in the training history (e.g., number of sessions, duration, etc.). Line 147: Add references for the questionnaires used. Line 161: Cite the supplementary materials. Line 174: Move the "Subjects" paragraph (renaming it "Participants") before the section "MightyU Game Application". Line 178: Replace "patients" with "children". Line 182: Clarify GMFCS Levels 1-4 and explain how they were used in the study. Line 187: Clarify the exclusion criteria. Line 189: Rename the paragraph to "Timing of Acquisition" and remove the reference to "measurement procedure". Lines 201-208: Specify which types of variables were analyzed and clarify which variables were measured in the study. RESULTS Line 210: Delete "subjects" and use "participants". Line 238: Rephrase "N = 3 children" as "3 children". Lines 249-254: The quartiles are not indicated in the results. Line 269: Delete "(N=1)"—it is clear in the text. Line 279: Rephrase "independent of the starting level" to "independently of the starting level". DISCUSSION Line 293: Clarify the use of "surface EMG sensor". Line 294: Use "muscle activation" instead of "muscle contraction". Avoid numbered lists; try to rephrase the points in narrative form. Line 313: Delete "N=" and replace "subjects" with "individuals". Line 336: Rephrase "sensor-based surface EMG (sEMG) technology". Line 347: Delete "N=". Lines 356-357: "Allowed the intensity of muscle contraction to be quantified"—How was this quantified? Please clarify the methodology. Line 363: Replace "affected" with "children with CP". Line 366: Remove the paragraph name "Interpretation". Line 386: Replace "level of disability" with "classification level". Explain the limitations of the study and the potential for future developments more clearly. CONCLUSION Avoid using "patients"; replace with "children" or a suitable synonym. TABLES Table 2: Use the same font throughout the table. Table 1 Caption: "Participants' Clinical Characteristics". Refer to Table 2 in the text when mentioning "muscles". FIGURES Figure 2: Add the statistical analysis performed to the figure. Figure 4: Replace "GMFC score" with "GMFCS level" and add a legend explaining the colors. GENERAL CONSIDERATIONS Revise the "Methods" section to use a more scientific tone. Provide the results with the respective statistical analyses. Clarify the type of variables used to control the game—only EMG amplitude? Some points could benefit from rephrasing to improve clarity. Add a photo of the experimental set up. Reviewer #4: Lynn Eitner and the group took the most trending virtual reality approach to develop a gamming concept as a therapeutic or rehabilitatory tool for cerebral palsy patients. To edge their virtual gaming competitive market, the authors combined sensor-based surface EMG technology as the human operating control for the video game, which can detect and record small muscle contractions over time. This gave the authors to tailor the game specifically for patient needs or disability, targeting muscle of interest which made the tool versatile. I really appreciate their thought process, and the authors conceptually contributed towards the merit of personalized therapeutic research. Here I would like to address a few important areas of my concern and highlighting the scope of improvement for the authors. Overall concerns: 1.The authors designed their manuscript around the virtual reality game, its development, tailoring to the patient needs, surveys, etc, but the aim of the article suggests ‘… exercise training of the children and adolescents with cerebral palsy’. They failed to mention any information regarding how their device or game improved the scientific or theoretical knowledge of treatment or therapeutic/rehabilitatory observations of their patient under study. 2.The game includes the sensors of EMG, that could have been their main focused since it was the bridge between virtual game development and scientific advancement in neuro-therapeutic field. There was no data provided in the current form of this article in this regard. In the discussion section authors promised to provide that in their future publications. I think it would be good to combine their present and future goals together to establish a story with good scientific merit. Concerns related to the current form of the article: 1.In the introduction, authors mentioned modification in the MightyU project (Page 5 line 69): Is the program upgradable? Meaning, is it possible to modify or adjust the difficulty level of the game in accordance with patients’ impairments and/or improvement? More justification would be appreciated for the readers. 2.Method section (page 6 line 80) suggests that the project has been approved by the ethics committee in 2020. The obvious question comes, why has there not been any follow up study conducted? 3.The game development section (Page 7 line 113) described the game. What is unique about the logic/algorithm of the game which makes this development unique and tailored to the patient as compared to their competitors’ product? Little more description would be helpful for the reader to understand the rational. 4.The section also talks about the use of EMG in the playing process and gaming score. The patient needs to contract or relax their muscles to keep the virtual player floating on the screen during the game. Can authors comment on whether the recording from EMG data pattern and the gaming score comparable? It would be helpful to directly relate their gamification process with therapeutic progress. 5.Measurement procedure (Page 10 line 190): Was the EMG data collected during the training, practice or trail sessions being used in medical research in any form? Was the data evaluated by the patient’s therapist? Detailed description of whether or how that data has been processed will give the article a justification for developing muscle targeted gamming device for CP patients. 6.Figure 3 required more explanation why the GEQ rating of healthy parents and children with CP are almost identical in terms of competence and challenge parameters. 7.Figure 4: The comparative line graphs show almost 70% cases where the GMFC score improved from 1st to 2nd assessment. Based on the gaming logic explained in this article, neurologically that graph implies strengthening of muscle or improvement on controlling muscle contraction/relaxation. These are very important parameters for CP therapeutic aspect. The question raises why this result has not been correlated with EMG data collected during the assessments? Reviewer #5: Thank you for this submission. This is an interesting study and the MightyU seems like a valuable addition to a home exercise program. *While the study appears to be sound, the language is sometimes unclear, making it difficult to follow. I advise the authors work with a writing coach or copyeditor to improve the flow and readability of the text. *I would recommend no beginning sentences with "N=XX" and use percentages and not 2/3 (line 304) when appropriate. This was noted only toward the end of the paper. *The description for the GMFCS level 4 participants in Figure 4 is listed as purple and violet. It would be best to pick on color descriptor (purple). *I would not call the MightyU a VR program. It is a game, but not virtual reality based on your description. *It would be interesting to see if the participants demonstrated increased contraction strength as a result of their use of the device. Is this information available or will this be a future study? *How often should this be re-calibrated during their use of the product? If I understand correctly, the device is calibrated to the participant once when treatment is initiated and then was not re-calibrated during the one-week trial. Reviewer #6: Overall summary This non-randomised, non-controlled experimental study measures the feasibility, acceptance, and intrinsic effectiveness (improvement of the same performance which is trained) of a novel rehabilitation videogame. The main strength of the study is the type of sensorisation which is employed, i.e. surface EMG. In fact, most human-machine interfaces are based on kinematic signals provided by motion-capture systems, whereas electromyography is seldom used. Another strong point is that different, disorder-specific muscles were targeted on the basis of physiotherapists' advice. Major weaknesses are: the game is very simple and looks rather repetitive, no measures of clinical effectiveness were taken, no control sample was recruited, the clinical sample is small and very diverse as far as functional impairment, topography of motor disorder, and intellectual disabilities are concerned. For these reasons, I consider it of poor scientific quality, though original and interesting for rehabilitation practice. I am thus in favour of its rejection. Answers to review questions 1) The manuscript isn't very sound because it doesn't fully decribe nor explain the experimental setup. Moreover, it doesn't include any clinical outcome measure nor controls of any sort. No hypotheses are made and therefore data can neither support nor reject the hypotheses. 2) Statistical analysis is virtually absent, since data are only descriptive. Some analysis has been carried out, but no conclusions can be drawn. 3) I couldn't find the full clinical description of cases, nor the association between clinical pictures (type, distribution of motor disorders) and experimental conditions. 4) The manuscript is written in standard English, but it hasn't been revised. Details by section Introduction Page 5, line 65. Please explicit the advantages of sEMG compared with other sensors for exergames. Page 5, line 78. Please add the expected results of your study. Methods Page 7, line 117. What is special about the sensors? Page 7, line 120. Setup specifications are not clear enough. Please add technical data such as latency and measurement errors. Please specify how many sensors were used and in which configuration. Cross-talk issues? Latency issues? Was the bluetooth connection for each sensor or were sensors cabled to a single transmitter? By the way, does each child use always the same muscle(s) for gearing the game? Does each child use one or more muscles at a time? Is game duration always the same or does it change according to levels? Procedure requires clarification. Page 7, line 122. Define 'muscle tension': which signal measure was used and how? Error? Page 7, line 123. Explain the calibration procedure. Page 9, line 170. How did you normalise the measure 'number of coins' across different levels, game durations (if variable), and muscles tested? Why didn't you investigate any clinical outcome measure, such as muscle strength, endurance, gross-motor function, attention, QoL? Results Page 12, line 220. Which 'hand joint' do you mean exactly, the radio-carpal joint? What does 'stretching their feet' mean, maybe plantar flexion? What CP type (topography and type of motor disorder) was matched with what muscles? Clinical characterisation is very poor. Discussion I expected to gain more insight into the pros and contras of this particular methodology in comparison with other 1) types of exergame, 2) types of sensorisation, 3) training methods. I haven't found much of the sort. Page 20, line 336. Unfinished sentence. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: Yes: Srikanya Kundu Reviewer #5: No Reviewer #6: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Eitner, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mshari Alghadier Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: (No Response) Reviewer #4: All comments have been addressed Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: N/A Reviewer #4: Yes Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** Reviewer #3: General comments The manuscript presents an interesting study on the use of a gamified sEMG-based application for home-based rehabilitation of children with cerebral palsy (CP). The work is well-structured, and the preliminary data are promising. However, several aspects require attention before submission: Abstract break long sentences, clarify the effect size (68% improvement). Include the number of participants in the Methods section of the abstract. Terminology and consistency Muscles: quadrizeps femoris → quadriceps femoris digitorum profundus palmarflexion → flexor digitorum profundus – wrist/finger flexion peroneus longus abduction → peroneus longus – foot eversion Correlation coefficient: replace “onkoeffic ient”. Standardize abbreviations: sEMG, EMG. Methods Break long sentences in the EMG sensor and gameplay descriptions. Use bullet points for technical parameters (A/D conversion, filtering, RMS). Clarify access to data on the web portal. Clearly describe the GEQ and SUS scales. line 223: remove ) at the end of the sentence Results Correct muscle names and movements in Table 2. Standardize data presentation across text, tables, and figures (percentages vs. medians). Check discrepancies between the number of participants reported in text and figures. Discussion Some sections are redundant (e.g., paragraphs 356–398). Avoid repetition of previously reported results. line 389 avoid to use patients. Children should be better. Explain the limitations of the study and the potential for future developments more clearly. Conclusions Simplify long sentences. Summarize in 2–3 concise sentences: safety, usability, motivation, potential for home-based training. Tables and figures Table 2: correct muscle names and movements. Figures 1–6: check readability and legends; standardize numbering. GEQ/SUS: standardize style and units. Table 3: replace a comma with . 0,32 -> 0.32 replace correlationkoefficent with "correlation coefficient" Figure 5: add "S" to "GMFC" Style and language Shorten long sentences and break overly complex periods. Standardize verb tense: past for methods, present for results and interpretation. Check punctuation, spacing, and terminological consistency. Conclusion The manuscript has high scientific potential. After correcting terminology, standardizing data, reducing redundancy, and improving style, it will be suitable for pubblicaiton. TABLE 2 I would correct the table as follows. Biceps brachii Flexion of the forearm Brachioradialis Flexion of the forearm / assists supination Flexor digitorum profundus Flexion of the fingers Extensor carpi radialis longus Extension of the wrist Extensor digitorum Extension of the fingers Tibialis anterior Dorsiflexion of the foot Quadriceps femoris Extension of the knee joint Peroneus longus Eversion of the foot Reviewer #4: All comments were address to the best of their ability and available data. The current manuscript has been considered as a first part of their ongoing reserach. Looking forward to their upcoming publication. Reviewer #5: Thank you for the opportunity to review this resubmission. A few minor comments. there is a typo in Table 3 Correlation Coefficient. Figure 5, left axis of the figure is hard to read, recommend labeling every 5 coins. This is a much better submission than the original. Thank you for addressing our concerns. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
MightyU – A portable sensor-based video game application for exercise training of children and adolescents with cerebral palsy PONE-D-24-54773R2 Dear Dr. Eitner, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mshari Alghadier Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: N/A Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: No Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #5: Yes ********** Reviewer #3: The review has been completed and I have no further comments. The document is clear, comprehensive, and consistent. It can be accepted. Reviewer #5: Thank you for addressing the concerns listed in the previous review. I have no further concerns about this submission. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #5: No ********** |
| Formally Accepted |
|
PONE-D-24-54773R2 PLOS One Dear Dr. Eitner, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mshari Alghadier Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .